Screening compound: C17H20F2N2O5S (T140-0766)

Screening compound: C<sub>17</sub>H<sub>20</sub>F<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S (T140-0766)
Screening compound: C<sub>17</sub>H<sub>20</sub>F<sub>2</sub>N<sub>2</sub>O<sub>5</sub>S (T140-0766) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C17H20F2N2O5S (T140-0766)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T140-0766

Molecular Formula

C17H20F2N2O5S (C17 H20 F2 N2 O5 S)

Compound Name

8-(3,5-difluorobenzoyl)-4-(2-methoxyethyl)-1lambda~6~-thia-4,8-diazaspiro[4.5]decane-1,1,3-trione

IUPAC name

8-(35-difluorobenzoyl)-4-(2-methoxyethyl)-1lambda6-thia-48-diazaspiro[4.5]decane-113-trione

SMILES

COCCN(C(CC1)(CCN1C(c1cc(F)cc(F)c1)=O)S(C1)(=O)=O)C1=O

InChI

InChI=1S/C17H20F2N2O5S/c1-26-7-6-21-15(22)11-27(24,25)17(21)2-4-20(5-3-17)16(23)12-8-13(18)10-14(19)9-12/h8-10H,2-7,11H2,1H3

InChI Key

UXEDJUXSYJGGHO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29011540

C17H20F2N2O5S (T140-0766) in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Nuclear receptors

References: we are preparing a list of scientific research reports with C17H20F2N2O5S (T140-0766) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C17H20F2N2O5S (T140-0766)?
Check Price and Availability of C17H20F2N2O5S (T140-0766), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C17H20F2N2O5S (T140-0766) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C17H20F2N2O5S (T140-0766)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C17H20F2N2O5S (T140-0766)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C17H20F2N2O5S (T140-0766) available by request